){kind=logo}
Breakfast Briefing: Foodtech x Healthspan - From Evidence to Shelf
- As GLP-1 adoption reshapes consumption patterns and consumers prioritize metabolic health and longevity, how should food and ingredient companies reposition portfolios around validated functionality? Where is demand structurally shifting across snacking, protein, fiber, satiety, and micronutrient fortification?
- What does it take to translate clinical evidence into scalable retail products, and what level of evidence is commercially meaningful verses aspirational?
- As food and pharma converge around personalized nutrition, where can food companies credibly expand into health-focused categories, and what partnerships (clinical, regulatory, digital, distribution) are required?
- How can brands communicate scientifically supported functionality without overstepping regulatory boundaries or eroding consumer trust?